Randy Thurman Insider Profile
4 Followers
Randy Thurman, Director at Outlook Therapeutics, holds 5.59K shares in Outlook Therapeutics (Ticker: OTLK), holds 0.00 shares in TFF Pharmaceuticals (Ticker: TFFP), holds 73.12K shares in Veradigm (Ticker: MDRX). Most recently, Randy Thurman Bought ― shares of Outlook Therapeutics on May 27, 2026 for an estimated value of $2.10K.
Profitable Transactions
6 out of 8 Profitable Transactions
Average Return
+62.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Randy Thurman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 15, 2020 - Sep 15, 2021
Return:+277.50%
The most profitable trade made by Randy Thurman
Randy Thurman's Trading History
Outlook Therapeutics
May 27, 2026
Director
Informative Buy
2.10K
$3.81K
TFF Pharmaceuticals
Sep 30, 2022
―
Uninformative Buy
100.64K
$0.00
Veradigm
May 24, 2017
Director
Uninformative Buy
―
$350.98K
Orthofix Medical
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Randy Thurman's performance on stock
You May Also Like
Randy Thurman insider profile FAQ
What is the percentage of profitable transactions made by Randy Thurman?
The percentage of profitable transactions made by Randy Thurman is 75%.
What is the average return per transaction made by Randy Thurman?
The average return per transaction made by Randy Thurman is 62.20%.
What stocks does Randy Thurman hold?
Randy Thurman holds: OTLK, TFFP, MDRX, OFIX stocks.
What was Randy Thurman’s latest transaction?
Randy Thurman latest transaction was an Informative Buy of $2.10K.
What was Randy Thurman's most profitable transaction?
Randy Thurman’s most profitable transaction was an Informative Buy of OTLK stock on September 15, 2020. The return on the trade was 277.50%.
What is Randy Thurman's role in Outlook Therapeutics?
Randy Thurman's role in Outlook Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.